Initiation of Research Coverage

RNS Number : 9154N
Emmerson PLC
26 May 2020
 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

26 May 2020

Emmerson Plc ("Emmerson" or the "Company")  

Initiation of Research Coverage

 

Emmerson Plc, the Moroccan focused potash development company, is pleased to announce that Align Research Limited has completed a comprehensive initiation equity research note on the Company.

 

The note covers the world class potential for its flagship Khemisset Potash Project ("Khemisset" or "the Project") focusing on its potential to be a low capital cost, high margin mine development and uses comparable analysis to provide context as to the potential of the Project.

 

To download the full note please visit the following link:

 

http://www.alignresearch.co.uk/cpt-company/emmerson/

 

**ENDS**

 

For further information, please visit www.emmersonplc.com , follow us on Twitter (@emmerson_plc), or contact: 

Hayden Locke

Emmerson Plc

Tel: +44 (0) 207 236 1177

Edward McDermott

 



Damon Heath

Shard Capital Partners

Tel: +44 ( 0) 20 7186 9950

Isabella Pierre






Isabel de Salis

Megan Dennison

St Brides Partners Ltd

Financial PR/IR

Tel: +44 (0) 20 7236 1177



 

Notes to Editors

Emmerson's primary focus is on developing the Khemisset Potash Project located in Northern Morocco.  The project has a large JORC Resource Estimate (2012) of 311.4Mt @ 10.2% K2O and significant exploration potential with an accelerated development pathway targeting a low capex, high margin mine.  Khemisset is perfectly located to capitalise on the expected growth of African fertiliser consumption whilst also being located on the doorstep of European markets. This unique positioning means the project will receive a premium netback price compared to existing potash producers. The need to feed the world's rapidly increasing population is driving demand for potash and Emmerson is well placed to benefit from the opportunities this presents.  


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRASEFSWMESSEDI

Companies

Emmerson NPV (EML)
UK 100